TRxADE HEALTH (NASDAQ:MEDS) Stock Price Down 5.4% – Time to Sell?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares dropped 5.4% during mid-day trading on Tuesday . The stock traded as low as $7.10 and last traded at $7.23. Approximately 11,922 shares changed hands during trading, a decline of 94% from the average daily volume of 207,831 shares. The stock had previously closed at $7.64.

TRxADE HEALTH Trading Down 5.4 %

The firm’s fifty day moving average price is $7.51 and its 200-day moving average price is $8.74.

Hedge Funds Weigh In On TRxADE HEALTH

A hedge fund recently bought a new stake in TRxADE HEALTH stock. Virtu Financial LLC purchased a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned 0.75% of TRxADE HEALTH as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 5.68% of the company’s stock.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.